A drug with the SMILES CCc1nnc(NC(=O)CSc2nc(C)nc3c2c(=O)n(C)c(=O)n3C)s1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of 13.008%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCc1nnc(NC(=O)CSc2nc(C)nc3c2c(=O)n(C)c(=O)n3C)s1
CCc1nnc(NC(=O)CSc2nc(C)nc3c2c(=O)n(C)c(=O)n3C)s1
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(1,3,7-trimethyl-2,4-dioxopyrimido[4,5-d]pyrimidin-5-yl)sulfanylacetamide